Foundations Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.8M Buy
65,706
+6,366
+11% +$6.5M 0.81% 23
2026
Q1
$54.6M Buy
59,340
+4,343
+8% +$4.4M 0.68% 39
2025
Q4
$59.1M Buy
54,997
+3,079
+6% +$2.94M 0.77% 33
2025
Q3
$39.6M Buy
51,918
+3,256
+7% +$2.42M 0.58% 45
2025
Q2
$37.9M Buy
48,662
+5,468
+13% +$4.25M 0.6% 48
2025
Q1
$35.7M Buy
43,194
+6,054
+16% +$5.04M 0.66% 38
2024
Q4
$28.7M Buy
37,140
+4,085
+12% +$3.38M 0.55% 45
2024
Q3
$29.3M Buy
33,055
+10,129
+44% +$9.11M 0.62% 38
2024
Q2
$20.8M Buy
22,926
+2,146
+10% +$1.72M 0.5% 49
2024
Q1
$16.2M Buy
20,780
+612
+3% +$436K 0.42% 59
2023
Q4
$13.3M Buy
20,168
+10,128
+101% +$5.91M 0.36% 62
2023
Q3
$5.39M Buy
10,040
+2,949
+42% +$1.52M 0.17% 104
2023
Q2
$3.33M Buy
7,091
+2,470
+53% +$1.04M 0.11% 134
2023
Q1
$1.59M Buy
4,621
+1,173
+34% +$396K 0.06% 187
2022
Q4
$1.26M Sell
3,448
-65
-2% -$23K 0.05% 184
2022
Q3
$1.14M Sell
3,513
-187
-5% -$59.2K 0.05% 155
2022
Q2
$1.22M Buy
3,700
+754
+26% +$226K 0.05% 122
2022
Q1
$889K Sell
2,946
-74
-2% -$19K 0.03% 136
2021
Q4
$773K Buy
3,020
+25
+0.8% +$6.34K 0.03% 151
2021
Q3
$692K Buy
2,995
+8
+0.3% +$1.97K 0.03% 140
2021
Q2
$702K Buy
2,987
+816
+38% +$164K 0.03% 128
2021
Q1
$396K Buy
+2,171
New +$425K 0.02% 151

Other funds holding LLY

Foundations Investment Advisors's LLY Position: Q2 2026 in Review

Foundations Investment Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $6.5M and bringing the position to 65,706 shares worth $78.8M. The position accounts for 0.81% of the portfolio, ranked #23.

Foundations Investment Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Foundations Investment Advisors held 65,706 shares of Eli Lilly worth $78.8M as of Q2 2026.
  • Foundations Investment Advisors bought 6,366 Eli Lilly shares in Q2 2026, an estimated $6.5M.
  • Eli Lilly made up 0.81% of Foundations Investment Advisors's portfolio in Q2 2026, its #23 holding.
  • Foundations Investment Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.